Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer

Background - The advanced lung cancer inflammation index [ALI: body mass index × serum albumin/neutrophil-to-lymphocyte ratio (NLR)] reflects systemic host inflammation, and is easily reproducible. We hypothesized that ALI could assist guidance of non-small-cell lung cancer (NSCLC) treatment with im...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mountzios, Giannis (VerfasserIn) , Samantas, E. (VerfasserIn) , Senghas, Karsten (VerfasserIn) , Zervas, E. (VerfasserIn) , Krisam, Johannes (VerfasserIn) , Samitas, K. (VerfasserIn) , Bozorgmehr, Farastuk (VerfasserIn) , Kuon, Jonas (VerfasserIn) , Agelaki, S. (VerfasserIn) , Baka, S. (VerfasserIn) , Athanasiadis, I. (VerfasserIn) , Gaißmaier, Lena (VerfasserIn) , Elshiaty, Mariam (VerfasserIn) , Daniello, Lea (VerfasserIn) , Christopoulou, A. (VerfasserIn) , Pentheroudakis, G. (VerfasserIn) , Lianos, E. (VerfasserIn) , Linardou, H. (VerfasserIn) , Kriegsmann, Katharina (VerfasserIn) , Kosmidis, P. (VerfasserIn) , El-Shafie, Rami (VerfasserIn) , Kriegsmann, Mark (VerfasserIn) , Psyrri, A. (VerfasserIn) , Andreadis, C. (VerfasserIn) , Fountzilas, E. (VerfasserIn) , Heußel, Claus Peter (VerfasserIn) , Herth, Felix (VerfasserIn) , Winter, Hauke (VerfasserIn) , Emmanouilides, C. (VerfasserIn) , Oikonomopoulos, G. (VerfasserIn) , Meister, Michael (VerfasserIn) , Muley, Thomas (VerfasserIn) , Bischoff, Helge (VerfasserIn) , Saridaki, Z. (VerfasserIn) , Razis, E. (VerfasserIn) , Perdikouri, E. -I. (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn) , Boukovinas, I. (VerfasserIn) , Reck, M. (VerfasserIn) , Syrigos, K. (VerfasserIn) , Thomas, Michael (VerfasserIn) , Christopoulos, Petros (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 September 2021
In: ESMO open
Year: 2021, Jahrgang: 6, Heft: 5, Pages: 1-10
ISSN:2059-7029
DOI:10.1016/j.esmoop.2021.100254
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.esmoop.2021.100254
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2059702921002167
Volltext
Verfasserangaben:G. Mountzios, E. Samantas, K. Senghas, E. Zervas, J. Krisam, K. Samitas, F. Bozorgmehr, J. Kuon, S. Agelaki, S. Baka, I. Athanasiadis, L. Gaissmaier, M. Elshiaty, L. Daniello, A. Christopoulou, G. Pentheroudakis, E. Lianos, H. Linardou, K. Kriegsmann, P. Kosmidis, R. El Shafie, M. Kriegsmann, A. Psyrri, C. Andreadis, E. Fountzilas, C.-P. Heussel, F.J. Herth, H. Winter, C. Emmanouilides, G. Oikonomopoulos, M. Meister, T. Muley, H. Bischoff, Z. Saridaki, E. Razis, E.-I. Perdikouri, A. Stenzinger, I. Boukovinas, M. Reck, K. Syrigos, M. Thomas & P. Christopoulos

MARC

LEADER 00000caa a2200000 c 4500
001 1787339289
003 DE-627
005 20240415193303.0
007 cr uuu---uuuuu
008 220127s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.esmoop.2021.100254  |2 doi 
035 |a (DE-627)1787339289 
035 |a (DE-599)KXP1787339289 
035 |a (OCoLC)1341439537 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
084 |a 33  |2 sdnb 
100 1 |a Mountzios, Giannis  |e VerfasserIn  |0 (DE-588)1225906423  |0 (DE-627)1745946349  |4 aut 
245 1 0 |a Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer  |c G. Mountzios, E. Samantas, K. Senghas, E. Zervas, J. Krisam, K. Samitas, F. Bozorgmehr, J. Kuon, S. Agelaki, S. Baka, I. Athanasiadis, L. Gaissmaier, M. Elshiaty, L. Daniello, A. Christopoulou, G. Pentheroudakis, E. Lianos, H. Linardou, K. Kriegsmann, P. Kosmidis, R. El Shafie, M. Kriegsmann, A. Psyrri, C. Andreadis, E. Fountzilas, C.-P. Heussel, F.J. Herth, H. Winter, C. Emmanouilides, G. Oikonomopoulos, M. Meister, T. Muley, H. Bischoff, Z. Saridaki, E. Razis, E.-I. Perdikouri, A. Stenzinger, I. Boukovinas, M. Reck, K. Syrigos, M. Thomas & P. Christopoulos 
264 1 |c 1 September 2021 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.01.2022 
520 |a Background - The advanced lung cancer inflammation index [ALI: body mass index × serum albumin/neutrophil-to-lymphocyte ratio (NLR)] reflects systemic host inflammation, and is easily reproducible. We hypothesized that ALI could assist guidance of non-small-cell lung cancer (NSCLC) treatment with immune checkpoint inhibitors (ICIs). - Patients and methods - This retrospective study included 672 stage IV NSCLC patients treated with programmed death-ligand 1 (PD-L1) inhibitors alone or in combination with chemotherapy in 25 centers in Greece and Germany, and a control cohort of 444 stage IV NSCLC patients treated with platinum-based chemotherapy without subsequent targeted or immunotherapy drugs. The association of clinical outcomes with biomarkers was analyzed with Cox regression models, including cross-validation by calculation of the Harrell's C-index. - Results - High ALI values (>18) were significantly associated with longer overall survival (OS) for patients receiving ICI monotherapy [hazard ratio (HR) = 0.402, P < 0.0001, n = 460], but not chemo-immunotherapy (HR = 0.624, P = 0.111, n = 212). Similar positive correlations for ALI were observed for objective response rate (36% versus 24%, P = 0.008) and time-on-treatment (HR = 0.52, P < 0.001), in case of ICI monotherapy only. In the control cohort of chemotherapy, the association between ALI and OS was weaker (HR = 0.694, P = 0.0002), and showed a significant interaction with the type of treatment (ICI monotherapy versus chemotherapy, P < 0.0001) upon combined analysis of the two cohorts. In multivariate analysis, ALI had a stronger predictive effect than NLR, PD-L1 tumor proportion score, lung immune prognostic index, and EPSILoN scores. Among patients with PD-L1 tumor proportion score ≥50% receiving first-line ICI monotherapy, a high ALI score >18 identified a subset with longer OS and time-on-treatment (median 35 and 16 months, respectively), similar to these under chemo-immunotherapy. - Conclusions - The ALI score is a powerful prognostic and predictive biomarker for patients with advanced NSCLC treated with PD-L1 inhibitors alone, but not in combination with chemotherapy. Its association with outcomes appears to be stronger than that of other widely used parameters. For PD-L1-high patients, an ALI score >18 could assist the selection of cases that do not need addition of chemotherapy. 
650 4 |a advanced lung cancer inflammation index 
650 4 |a immunotherapy 
650 4 |a neutrophil-to-lymphocyte ratio 
650 4 |a non-small-cell lung cancer 
650 4 |a PD-L1 
700 1 |a Samantas, E.  |e VerfasserIn  |4 aut 
700 1 |a Senghas, Karsten  |e VerfasserIn  |0 (DE-588)1210442388  |0 (DE-627)1698468938  |4 aut 
700 1 |a Zervas, E.  |e VerfasserIn  |4 aut 
700 1 |a Krisam, Johannes  |d 1986-  |e VerfasserIn  |0 (DE-588)1016031343  |0 (DE-627)705475034  |0 (DE-576)351438696  |4 aut 
700 1 |a Samitas, K.  |e VerfasserIn  |4 aut 
700 1 |a Bozorgmehr, Farastuk  |d 1979-  |e VerfasserIn  |0 (DE-588)141921811  |0 (DE-627)632526734  |0 (DE-576)326848150  |4 aut 
700 1 |a Kuon, Jonas  |e VerfasserIn  |0 (DE-588)1166909484  |0 (DE-627)1030803730  |0 (DE-576)510963129  |4 aut 
700 1 |a Agelaki, S.  |e VerfasserIn  |4 aut 
700 1 |a Baka, S.  |e VerfasserIn  |4 aut 
700 1 |a Athanasiadis, I.  |e VerfasserIn  |4 aut 
700 1 |a Gaißmaier, Lena  |d 1996-  |e VerfasserIn  |0 (DE-588)1250460697  |0 (DE-627)1787337537  |4 aut 
700 1 |a Elshiaty, Mariam  |e VerfasserIn  |0 (DE-588)1237666333  |0 (DE-627)1764596110  |4 aut 
700 1 |a Daniello, Lea  |d 1997-  |e VerfasserIn  |0 (DE-588)1238304303  |0 (DE-627)1765667739  |4 aut 
700 1 |a Christopoulou, A.  |e VerfasserIn  |4 aut 
700 1 |a Pentheroudakis, G.  |e VerfasserIn  |4 aut 
700 1 |a Lianos, E.  |e VerfasserIn  |4 aut 
700 1 |a Linardou, H.  |e VerfasserIn  |4 aut 
700 1 |a Kriegsmann, Katharina  |d 1986-  |e VerfasserIn  |0 (DE-588)1049422449  |0 (DE-627)781924006  |0 (DE-576)40339774X  |4 aut 
700 1 |a Kosmidis, P.  |e VerfasserIn  |4 aut 
700 1 |a El-Shafie, Rami  |d 1989-  |e VerfasserIn  |0 (DE-588)110057378X  |0 (DE-627)859521427  |0 (DE-576)469743859  |4 aut 
700 1 |a Kriegsmann, Mark  |d 1987-  |e VerfasserIn  |0 (DE-588)103740324X  |0 (DE-627)755668782  |0 (DE-576)39141870X  |4 aut 
700 1 |a Psyrri, A.  |e VerfasserIn  |4 aut 
700 1 |a Andreadis, C.  |e VerfasserIn  |4 aut 
700 1 |a Fountzilas, E.  |e VerfasserIn  |4 aut 
700 1 |a Heußel, Claus Peter  |e VerfasserIn  |0 (DE-588)1048631389  |0 (DE-627)780769422  |0 (DE-576)40288146X  |4 aut 
700 1 |a Herth, Felix  |e VerfasserIn  |0 (DE-588)1016095236  |0 (DE-627)705477568  |0 (DE-576)351509925  |4 aut 
700 1 |a Winter, Hauke  |e VerfasserIn  |0 (DE-588)1162076038  |0 (DE-627)1025509773  |0 (DE-576)176791531  |4 aut 
700 1 |a Emmanouilides, C.  |e VerfasserIn  |4 aut 
700 1 |a Oikonomopoulos, G.  |e VerfasserIn  |4 aut 
700 1 |a Meister, Michael  |e VerfasserIn  |0 (DE-588)1078792046  |0 (DE-627)839461402  |0 (DE-576)451890108  |4 aut 
700 1 |a Muley, Thomas  |e VerfasserIn  |0 (DE-588)1056885432  |0 (DE-627)794179169  |0 (DE-576)16759284X  |4 aut 
700 1 |a Bischoff, Helge  |d 1958-  |e VerfasserIn  |0 (DE-588)111184576  |0 (DE-627)389658286  |0 (DE-576)167287249  |4 aut 
700 1 |a Saridaki, Z.  |e VerfasserIn  |4 aut 
700 1 |a Razis, E.  |e VerfasserIn  |4 aut 
700 1 |a Perdikouri, E. -I.  |e VerfasserIn  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Boukovinas, I.  |e VerfasserIn  |4 aut 
700 1 |a Reck, M.  |e VerfasserIn  |4 aut 
700 1 |a Syrigos, K.  |e VerfasserIn  |4 aut 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
700 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
773 0 8 |i Enthalten in  |t ESMO open  |d [London] : Elsevier, 2016  |g 6(2021), 5, Artikel-ID 100254, Seite 1-10  |h Online-Ressource  |w (DE-627)84705344X  |w (DE-600)2844985-X  |w (DE-576)454658516  |x 2059-7029  |7 nnas  |a Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer 
773 1 8 |g volume:6  |g year:2021  |g number:5  |g elocationid:100254  |g pages:1-10  |g extent:10  |a Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer 
856 4 0 |u https://doi.org/10.1016/j.esmoop.2021.100254  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S2059702921002167  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220127 
992 |a 20220127 
993 |a Article 
993 |a Article 
994 |a 2021 
994 |a 2021 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |e 50000PC138659702  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 42  |y j 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PT1054438781  |e 950000PT1054438781  |e 950900PT1054438781  |e 50000PT1054438781  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 41 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 37 
998 |g 111184576  |a Bischoff, Helge  |m 111184576:Bischoff, Helge  |d 910000  |d 950000  |d 950900  |e 910000PB111184576  |e 950000PB111184576  |e 950900PB111184576  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 33 
998 |g 1056885432  |a Muley, Thomas  |m 1056885432:Muley, Thomas  |d 910000  |d 950000  |d 950900  |e 910000PM1056885432  |e 950000PM1056885432  |e 950900PM1056885432  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 32 
998 |g 1078792046  |a Meister, Michael  |m 1078792046:Meister, Michael  |d 910000  |d 950000  |d 950900  |e 910000PM1078792046  |e 950000PM1078792046  |e 950900PM1078792046  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 31 
998 |g 1162076038  |a Winter, Hauke  |m 1162076038:Winter, Hauke  |d 50000  |e 50000PW1162076038  |k 0/50000/  |p 28 
998 |g 1016095236  |a Herth, Felix  |m 1016095236:Herth, Felix  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1016095236  |e 950000PH1016095236  |e 950900PH1016095236  |e 50000PH1016095236  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 27 
998 |g 1048631389  |a Heußel, Claus Peter  |m 1048631389:Heußel, Claus Peter  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1048631389  |e 950000PH1048631389  |e 950900PH1048631389  |e 50000PH1048631389  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 26 
998 |g 103740324X  |a Kriegsmann, Mark  |m 103740324X:Kriegsmann, Mark  |d 910000  |d 912000  |d 50000  |e 910000PK103740324X  |e 912000PK103740324X  |e 50000PK103740324X  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 22 
998 |g 110057378X  |a El-Shafie, Rami  |m 110057378X:El-Shafie, Rami  |d 50000  |e 50000PE110057378X  |k 0/50000/  |p 21 
998 |g 1049422449  |a Kriegsmann, Katharina  |m 1049422449:Kriegsmann, Katharina  |d 910000  |d 910100  |e 910000PK1049422449  |e 910100PK1049422449  |k 0/910000/  |k 1/910000/910100/  |p 19 
998 |g 1238304303  |a Daniello, Lea  |m 1238304303:Daniello, Lea  |d 50000  |e 50000PD1238304303  |k 0/50000/  |p 14 
998 |g 1237666333  |a Elshiaty, Mariam  |m 1237666333:Elshiaty, Mariam  |d 50000  |e 50000PE1237666333  |k 0/50000/  |p 13 
998 |g 1250460697  |a Gaißmaier, Lena  |m 1250460697:Gaißmaier, Lena  |d 50000  |e 50000PG1250460697  |k 0/50000/  |p 12 
998 |g 1166909484  |a Kuon, Jonas  |m 1166909484:Kuon, Jonas  |d 50000  |e 50000PK1166909484  |k 0/50000/  |p 8 
998 |g 141921811  |a Bozorgmehr, Farastuk  |m 141921811:Bozorgmehr, Farastuk  |d 910000  |d 950000  |d 950900  |e 910000PB141921811  |e 950000PB141921811  |e 950900PB141921811  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 7 
998 |g 1016031343  |a Krisam, Johannes  |m 1016031343:Krisam, Johannes  |d 910000  |d 911800  |e 910000PK1016031343  |e 911800PK1016031343  |k 0/910000/  |k 1/910000/911800/  |p 5 
998 |g 1210442388  |a Senghas, Karsten  |m 1210442388:Senghas, Karsten  |d 910000  |d 950000  |d 950900  |e 910000PS1210442388  |e 950000PS1210442388  |e 950900PS1210442388  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 3 
999 |a KXP-PPN1787339289  |e 404596665X 
999 |a KXP-PPN1787339289  |e 4045966641 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 27.01.2022"],"origin":[{"dateIssuedDisp":"1 September 2021","dateIssuedKey":"2021"}],"title":[{"title_sort":"Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer","title":"Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["G. Mountzios, E. Samantas, K. Senghas, E. Zervas, J. Krisam, K. Samitas, F. Bozorgmehr, J. Kuon, S. Agelaki, S. Baka, I. Athanasiadis, L. Gaissmaier, M. Elshiaty, L. Daniello, A. Christopoulou, G. Pentheroudakis, E. Lianos, H. Linardou, K. Kriegsmann, P. Kosmidis, R. El Shafie, M. Kriegsmann, A. Psyrri, C. Andreadis, E. Fountzilas, C.-P. Heussel, F.J. Herth, H. Winter, C. Emmanouilides, G. Oikonomopoulos, M. Meister, T. Muley, H. Bischoff, Z. Saridaki, E. Razis, E.-I. Perdikouri, A. Stenzinger, I. Boukovinas, M. Reck, K. Syrigos, M. Thomas & P. Christopoulos"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"part":{"volume":"6","extent":"10","text":"6(2021), 5, Artikel-ID 100254, Seite 1-10","issue":"5","pages":"1-10","year":"2021"},"language":["eng"],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"id":{"zdb":["2844985-X"],"issn":["2059-7029"],"eki":["84705344X"]},"recId":"84705344X","name":{"displayForm":["European Society for Medical Oncology"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerESMO open","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 13.06.24"],"pubHistory":["1.2016 -"],"origin":[{"publisherPlace":"[London] ; London","dateIssuedDisp":"2016-","dateIssuedKey":"2016","publisher":"Elsevier ; BMJ"}],"title":[{"title_sort":"ESMO open","subtitle":"cancer horizons","title":"ESMO open"}]}],"recId":"1787339289","id":{"doi":["10.1016/j.esmoop.2021.100254"],"eki":["1787339289"]},"person":[{"given":"Giannis","role":"aut","family":"Mountzios","display":"Mountzios, Giannis"},{"display":"Samantas, E.","family":"Samantas","given":"E.","role":"aut"},{"display":"Senghas, Karsten","family":"Senghas","role":"aut","given":"Karsten"},{"role":"aut","given":"E.","display":"Zervas, E.","family":"Zervas"},{"role":"aut","given":"Johannes","display":"Krisam, Johannes","family":"Krisam"},{"family":"Samitas","display":"Samitas, K.","given":"K.","role":"aut"},{"family":"Bozorgmehr","display":"Bozorgmehr, Farastuk","given":"Farastuk","role":"aut"},{"role":"aut","given":"Jonas","display":"Kuon, Jonas","family":"Kuon"},{"family":"Agelaki","display":"Agelaki, S.","given":"S.","role":"aut"},{"role":"aut","given":"S.","family":"Baka","display":"Baka, S."},{"family":"Athanasiadis","display":"Athanasiadis, I.","role":"aut","given":"I."},{"role":"aut","given":"Lena","display":"Gaißmaier, Lena","family":"Gaißmaier"},{"role":"aut","given":"Mariam","display":"Elshiaty, Mariam","family":"Elshiaty"},{"display":"Daniello, Lea","family":"Daniello","role":"aut","given":"Lea"},{"given":"A.","role":"aut","display":"Christopoulou, A.","family":"Christopoulou"},{"given":"G.","role":"aut","family":"Pentheroudakis","display":"Pentheroudakis, G."},{"given":"E.","role":"aut","display":"Lianos, E.","family":"Lianos"},{"given":"H.","role":"aut","family":"Linardou","display":"Linardou, H."},{"display":"Kriegsmann, Katharina","family":"Kriegsmann","role":"aut","given":"Katharina"},{"display":"Kosmidis, P.","family":"Kosmidis","given":"P.","role":"aut"},{"given":"Rami","role":"aut","display":"El-Shafie, Rami","family":"El-Shafie"},{"role":"aut","given":"Mark","family":"Kriegsmann","display":"Kriegsmann, Mark"},{"given":"A.","role":"aut","family":"Psyrri","display":"Psyrri, A."},{"given":"C.","role":"aut","family":"Andreadis","display":"Andreadis, C."},{"given":"E.","role":"aut","family":"Fountzilas","display":"Fountzilas, E."},{"display":"Heußel, Claus Peter","family":"Heußel","role":"aut","given":"Claus Peter"},{"display":"Herth, Felix","family":"Herth","role":"aut","given":"Felix"},{"display":"Winter, Hauke","family":"Winter","role":"aut","given":"Hauke"},{"given":"C.","role":"aut","family":"Emmanouilides","display":"Emmanouilides, C."},{"family":"Oikonomopoulos","display":"Oikonomopoulos, G.","role":"aut","given":"G."},{"role":"aut","given":"Michael","family":"Meister","display":"Meister, Michael"},{"family":"Muley","display":"Muley, Thomas","role":"aut","given":"Thomas"},{"display":"Bischoff, Helge","family":"Bischoff","given":"Helge","role":"aut"},{"family":"Saridaki","display":"Saridaki, Z.","given":"Z.","role":"aut"},{"role":"aut","given":"E.","display":"Razis, E.","family":"Razis"},{"role":"aut","given":"E. -I.","family":"Perdikouri","display":"Perdikouri, E. -I."},{"given":"Albrecht","role":"aut","display":"Stenzinger, Albrecht","family":"Stenzinger"},{"family":"Boukovinas","display":"Boukovinas, I.","role":"aut","given":"I."},{"family":"Reck","display":"Reck, M.","role":"aut","given":"M."},{"display":"Syrigos, K.","family":"Syrigos","role":"aut","given":"K."},{"role":"aut","given":"Michael","family":"Thomas","display":"Thomas, Michael"},{"family":"Christopoulos","display":"Christopoulos, Petros","given":"Petros","role":"aut"}],"language":["eng"]} 
SRT |a MOUNTZIOSGASSOCIATIO1202